Create a consumer-accessible cutting-edge tool for measuring the aging process based on epigenetic analysis and biomedical data that will help personalize lifestyles and accelerate the creation of new interventions to slow down aging
Mission
Why now?
1
There are a large number of supplements and lifestyle tips that help to improve health and slow down aging, but it is not clear whether they will help each individual and how to measure their effects.
2
The current complicated classification of blood markers makes it difficult to comprehend and requires lab visits and painful blood tests, which results can be controversial and not so accurate f in determining the real rate of aging.
3
Today's technologies have just begun to estimate the average biological age of a person, but these technologies are not yet precise enough and need to be improved.
4
There are a large number of potential pro-longevity interventions in the longevity industry that will take decades to prove effective.
5
The longevity industry is now in dire need of speedy and accurate identifying of reliable aging markers in order to expedite establishing potential longevity interventions.
Improved biological age-determination technology
Solution
Coming soon
Faster, cheaper, more accurate, and specifically targeted
The mobile application for collecting additional biomarkers and comprehensive personalized recommendations to slow down aging
API and SDK for vendors
Over the past 10 years, science has gained a modern and reliable way to measure not only the various biomarkers associated with diseases, but the root cause of disease - aging. With the help of modern technologies in molecular biology and genetics, we are able to measure the rate of cell aging, which is reflected in the pattern of DNA methylation and is called epigenetic age.
Epigenetics is the study of how our environment and lifestyle affect the way our genes work. Thanks to epigenetic signatures, we can study the influence of various substances and lifestyle on the work of genes associated with human aging. And with the help of AI, we can get closer to the personalization of medicines and the individual selection of the optimal prolongation strategy.
Future of epigenetics?
Team
We are a star team from Ukraine
Ivan Bolonikhin
CEO, Co-founder
Alexander Koliada
CSO, Co-founder
Denys Sakharov
CMO, Co-founder
Anton Rutkovsky
CPO
Oleksii Kryzhanovskyi
COO
Anton Shulyk
CFO
Egor Tiurin
Business Development, Legal
Advisors
Anastasiia Kamenska
PhD, Director of Corporate Strategy in Novartis
Vadim Gladyshev
Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Dariia Vasylieva
Strategy & Finance
Nadiia Kryzhanovska
MD, PhD Cardiology. Cardioprevention
Contacts
info@epigee.ai
1521 Concord Pike Ste 301 #329 Wilmington, DE 19803 United States
Beta Application
Please enter your contact info and we will reach out with an invite to our beta.